incidence of pancreatitis with glp 1 Glucagon-like peptide-1 receptor agonists and risk gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials Pancreatitis Risk Associated with GLP-1

Microglial activation and hypothalamic structural plasticity in HFD metabolic research [PMID: 39724960] Laboratory literature summary: Microglial activation and hypothalamic structural plasticity in HFD metabolic research models: insights from semaglutide and minocycline

Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al (1998)

Eng modified and purified exendin-4 into a drug form called exenatide, which became the first GLP-1 medication: Byetta (approved in 2005)

This work was funded by the National Key R&D Program of China (2022YFA1302902 to W.S

Nr vi ftt in frsljningsdata bearbetas den av SCB -Statistiska Centralbyrn, s att vi tillsammans kan producera aktuell, trovrdig och samlad bostadsstatistik.